Anthony Kirck
Comptroller/Controller/Auditor presso OPTINOSE, INC.
Patrimonio netto: 149 099 $ in data 30/06/2024
Profilo
Anthony J.
Kirck's current job is Chief Accounting Officer, VP-Finance & Controller at OptiNose, Inc. His former jobs include Executive Director-Financial Planning & Analysis at Strongbridge Biopharma Plc from 2017 to 2020, and Controller at Verrica Pharmaceuticals, Inc. from 2020 to 2021.
He completed his undergraduate degree at Albright College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
OPTINOSE, INC.
0.10% | 18/06/2024 | 143 364 ( 0.10% ) | 149 099 $ | 30/06/2024 |
Posizioni attive di Anthony Kirck
| Società | Posizione | Inizio |
|---|---|---|
| OPTINOSE, INC. | Comptroller/Controller/Auditor | 01/11/2021 |
Precedenti posizioni note di Anthony Kirck
| Società | Posizione | Fine |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 01/11/2021 |
| STRONGBRIDGE BIOPHARMA | Corporate Officer/Principal | 01/02/2020 |
Formazione di Anthony Kirck
| Albright College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| OPTINOSE, INC. | Health Technology |
| VERRICA PHARMACEUTICALS INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
- Borsa valori
- Insiders
- Anthony Kirck
